law

R.I. part of $950M Vioxx settlement

Posted 11/23/11

PROVIDENCE – Rhode Island will receive $917,453 as part of a $950 million settlement with pharmaceutical giant, Merck Sharp & Dohme Corp.

Merck is settling civil and criminal allegations that it marketed its drug Vioxx for uses not approved by the U.S. Food and Drug Administration; misrepresented the cardiovascular safety issues related to the drug; and other false and misleading representations.

Vioxx, a non-steroidal anti-inflammatory medication, for treating osteoarthritis, acute pain conditions and dysmenorrhea, was withdrawn from the market on Sept. 30, 2004, due to an “increase in the incidence of adverse cardiovascular events” in those taking the drug.

The company will pay $628.3 million to resolve civil claims to federal health care programs “for harm suffered as a result of this conduct.”

Merck has also agreed to plead guilty to violating the Food, Drug and Cosmetic Act and pay a fine of $321.6 million for illegal marketing of Vioxx as a treatment of rheumatoid arthritis. It was not approved by the FDA for treatment of the disease until 2002 but was introduced into the market in 1999.

The civil settlements are contingent on the U.S. District Court for the District of Massachusetts accepting Merck’s guilty plea. A hearing date has not yet been scheduled.

“Pharmaceutical companies are driven to off-label marketing of prescription drugs, like Vioxx, to boost profits despite the potential risks to patients’ health and safety,” said R.I. Attorney General Peter Kilmartin. “Merck’s false representations concerning the safety of Vioxx diverted Medicaid funds from legitimate programs to corporate profits to the detriment of taxpayers and patients.”

Calendar
PBN Hosted
Events

DEADLINE EXTENDED to Friday, October 3rd for applications for the 14th Annual Business Excellence Awards Program. And save the date for the Awards Dinner - November 12th at the Providence Marriott.
Advertisement
Purchase Data
Book of Lists
Lists
Book of Lists cover
PBN's annual Book of Lists has been an essential resource for the local business community for almost 30 years. The Book of Lists features a wealth of company rankings from a variety of fields and industries, including banking, health care, real estate, law, hospitality, education, not-for-profits, technology and many more.
Data icons
Data can be purchased as single lists, in either Excel or PDF format; the entire database of the published book, in Excel format; or a printed copy of the Book of Lists.
  • Purchase an e-File of a single list
  •  
  • Purchase an e-File of the entire Book of Lists database
  •  
  • Purchase a printed copy of the Book of Lists
  •  
    National
    Local
    Latest News
    Advertisement